Colorectal cancer control: Where have we been and where should we go next?
A partir d'une revue systématique de la littérature publiée entre 1996 et 2017 (73 essais incluant au total 366 766 patients), cette méta-analyse évalue l'efficacité des interventions mises en place aux Etats-Unis pour améliorer le taux de personnes ayant accompli la totalité des tests et examens recommandés dans le cadre du dépistage du cancer colorectal
Colorectal cancer (CRC) is the second leading cause of cancer death in the United States, but it does not have to be. Screening prevents CRC by finding precancerous lesions so they can be removed before they become cancerous. Screening can also detect CRC early and, when CRC is localized, 5-year survival is over 90%, with many patients cured. Five-year survival for late-stage CRC, however, is less than 20%.
JAMA Internal Medicine , commentaire, 2017